Table 3

Comparisons of total and individual diary card scores for dyspnoea, sputum colour, and sputum volume for patients in the purulent group receiving 5 versus 10 days antibiotic treatment and those in the mucoid group receiving inhaled fluticasone versus placebo

PresentationDay 5End of treatmentStable state
5 days10 daysFPPlacebo5 days10 daysFPPlacebo5 days10 daysFPPlacebo5 days10 daysFPPlacebo
Total score
Mean (SE)20.5 (1.1)18.7 (1.4)16.1 (1.2)16.5 (1.6)13.9 (0.7)12.2 (1.2)14.7 (1.1)14.5 (1.1)12.0 (0.8)10.8 (1.0)12.5 (1.3)13.0 (1.1)13.1 (1.3)10.5 (1.6)14.7 (1.3)13.2 (1.2)
Mean difference (95% CI)1.9
(–1.6 to 5.4)
–0.4 (–4.6 to 3.7)1.6 (–1.2 to 4.4)0.2 (–3.0 to 3.5)1.2 (–1.4 to 3.8)–0.5 (–4.4 to 3.4)2.6 (–1.5 to 6.7)1.5 (–2.2 to 5.3)
p value0.2200.2350.1790.4160.2400.4580.1530.271
Dyspnoea
Mean (SE)3.1 (0.2)2.7 (0.2)2.7 (0.2)3.0 (0.3)2.0 (0.1)2.1 (0.2)2.4 (0.2)2.3 (0.2)2.0 (0.1)1.8 (0.2)2.1 (0.2)2.2 (0.2)2.2 (0.2)1.7 (0.2)2.3 (0.2)2.1 (0.2)
Mean difference (95% CI)0.4 (–0.1 to 0.9)–0.3 (–0.9 to 0.3)–0.1 (–0.5 to 0.3)0.1 (–0.6 to 0.7)0.2 (–0.3 to 0.6)–0.1 (–0.7 to 0.5)0.4 (–0.1 to 1.0)0.1 (–0.6 to 0.9)
p value0.0690.2070.3840.4640.2960.3690.1080.420
Colour
Mean (SE)3.5 (0.2)3.6 (0.2)1.8 (0.2)2.0 (0.3)2.3 (0.2)2.1 (0.3)1.9 (0.3)2.5 (0.3)1.8 (0.2)1.7 (0.3)1.8 (0.3)2.0 (0.3)1.9 (0.2)1.7 (0.3)1.8 (0.2)2.4 (0.2)
Mean difference (95% CI)–0.1 (–0.7 to 0.5)–0.2 (–0.9 to 0.4)0.2 (–0.6 to 1.0)–0.6 (–1.4 to 0.3)0.1 (–0.6 to 0.8)–0.2 (–1.3 to 0.8)0.2 (–0.5 to 0.9)0.3 (–1.2 to 0.1)
p value0.3920.2780.2750.0930.4260.3010.2470.065
Volume
Mean (SE)1.7 (0.1)1.6 (0.2)1.8 (0.2)1.5 (0.2)1.3 (0.1)1.0 (0.2)1.6 (0.1)1.3 (0.2)1.1 (0.1)0.8 (0.1)1.4 (0.2)1.1 (0.2)1.2 (0.1)0.9 (0.2)1.5 (0.2)1.3 (0.2)
Mean difference (95% CI)0.1 (–0.4 to 0.5)0.3 (–0.3 to 0.9)0.3 (–0.2 to 0.7)0.3 (–0.1 to 0.7)0.3 (–0.1 to 0.7)0.3 (–0.4 to 0.9)0.2 (–0.2 to 0.7)0.2 (–0.5 to 0.9)
p value0.4260.1680.0980.1040.0940.1790.1760.300
  • 5 days = 5 days antibiotic treatment; 10 days = 10 days antibiotic treatment; FP = inhaled fluticasone.